These discoveries led to a resurgence of interest in cholinesterases as an important target in the therapy of Alzheimer’s disease, and numerous research groups have undertaken investigations concerning design and synthesis of new inhibitors [6,7]. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.